Interacting Drugs |
Bacitracin, neomycin, and polymyxin B vs RimabotulinumtoxinB |
Security Level |
 |
Mechanism |
RimabotulinumtoxinB: Aminoglycosides may enhance the neuromuscular-blocking effect of RimabotulinumtoxinB. |
Management |
Monitor therapy |
Bacitracin, neomycin, and polymyxin B vs RimabotulinumtoxinB
Post Review about Bacitracin, neomycin, and polymyxin B vs RimabotulinumtoxinB Click here to cancel reply.
Other Interactions of Bacitracin, neomycin, and polymyxin B
Other Interactions of RimabotulinumtoxinB
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.